re: News: Biotron's Hep C drug candidate phas... Giddy, your reasoning is logical and I suspect a few people are doing just this and that is one of the reasons why the sp is holding down. If you have shares and options and intend to exercise them it makes sense to sell enough of the normal shares to cover the cost - as long as the difference between selling the shares and paying the 10c + option price is positive.
So my guess is there are people who paid 2c for options attempting to sell at .13 or .125. This tends to hold the price down and has a feedback into the price of options which are always going to sell a little under the going price of shares less 10c. In this scenario, it's unlikely many will sell under .125 as they won't get much if any gain with their options at current levels. It's also unlikley buyers are going to be attracted to pay any more as they are just going to wait for these kinds of sales and pick the shares up relatively cheaply.
Result - stagnation.
Imo, it would likely pay people selling for this reason to hold off for a while. They'll do much better!
I'd be a buy except for this.
- Forums
- ASX - By Stock
- News: Biotron's Hep C drug candidate phase 2a tri
re: News: Biotron's Hep C drug candidate phas... Giddy, your...
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.46M |
Open | High | Low | Value | Volume |
2.5¢ | 2.6¢ | 2.5¢ | $23.83K | 953.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 141000 | 2.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.5¢ | 36000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 141000 | 0.024 |
2 | 153913 | 0.023 |
5 | 4220555 | 0.022 |
1 | 250000 | 0.021 |
3 | 250000 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.025 | 36000 | 1 |
0.026 | 47379 | 2 |
0.027 | 161989 | 2 |
0.028 | 400000 | 2 |
0.029 | 305600 | 3 |
Last trade - 15.15pm 22/08/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online